These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11313470)

  • 21. Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity.
    Fernet M; Mégnin-Chanet F; Hall J; Favaudon V
    DNA Repair (Amst); 2010 Jan; 9(1):48-57. PubMed ID: 19926348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cell cycle in mediating sensitivity to radiotherapy.
    Pawlik TM; Keyomarsi K
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):928-42. PubMed ID: 15234026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A UVR-induced G2-phase checkpoint response to ssDNA gaps produced by replication fork bypass of unrepaired lesions is defective in melanoma.
    Wigan M; Pinder A; Giles N; Pavey S; Burgess A; Wong S; Sturm RA; Gabrielli B
    J Invest Dermatol; 2012 Jun; 132(6):1681-8. PubMed ID: 22402442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1.
    Ree AH; Bratland A; Nome RV; Stokke T; Fodstad Ø
    Oncogene; 2003 Dec; 22(55):8952-5. PubMed ID: 14654792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATR affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining.
    Wang H; Wang H; Powell SN; Iliakis G; Wang Y
    Cancer Res; 2004 Oct; 64(19):7139-43. PubMed ID: 15466211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization.
    Okada S; Ouchi T
    J Biol Chem; 2003 Jan; 278(3):2015-20. PubMed ID: 12427729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function.
    Arlt MF; Xu B; Durkin SG; Casper AM; Kastan MB; Glover TW
    Mol Cell Biol; 2004 Aug; 24(15):6701-9. PubMed ID: 15254237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1 is a cell cycle-regulated nuclear phosphoprotein.
    Ruffner H; Verma IM
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7138-43. PubMed ID: 9207057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell cycle checkpoints and their inactivation in human cancer.
    Molinari M
    Cell Prolif; 2000 Oct; 33(5):261-74. PubMed ID: 11063129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the cell cycle G(2) delay assay in assessing ionizing radiation sensitivity and breast cancer risk.
    Hill JW; Tansavatdi K; Lockett KL; Allen GO; Takita C; Pollack A; Hu JJ
    Cancer Manag Res; 2009 Apr; 1():39-48. PubMed ID: 21188122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
    Miki Y; Swensen J; Shattuck-Eidens D; Futreal PA; Harshman K; Tavtigian S; Liu Q; Cochran C; Bennett LM; Ding W
    Science; 1994 Oct; 266(5182):66-71. PubMed ID: 7545954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.
    Yarden RI; Pardo-Reoyo S; Sgagias M; Cowan KH; Brody LC
    Nat Genet; 2002 Mar; 30(3):285-9. PubMed ID: 11836499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.
    Xu B; O'Donnell AH; Kim ST; Kastan MB
    Cancer Res; 2002 Aug; 62(16):4588-91. PubMed ID: 12183412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome maintenance mechanisms for preventing cancer.
    Hoeijmakers JH
    Nature; 2001 May; 411(6835):366-74. PubMed ID: 11357144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations.
    Dedes KJ; Wilkerson PM; Wetterskog D; Weigelt B; Ashworth A; Reis-Filho JS
    Cell Cycle; 2011 Apr; 10(8):1192-9. PubMed ID: 21487248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage.
    Johnson N; Cai D; Kennedy RD; Pathania S; Arora M; Li YC; D'Andrea AD; Parvin JD; Shapiro GI
    Mol Cell; 2009 Aug; 35(3):327-39. PubMed ID: 19683496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
    Bryant HE; Schultz N; Thomas HD; Parker KM; Flower D; Lopez E; Kyle S; Meuth M; Curtin NJ; Helleday T
    Nature; 2005 Apr; 434(7035):913-7. PubMed ID: 15829966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer susceptibility and the functions of BRCA1 and BRCA2.
    Venkitaraman AR
    Cell; 2002 Jan; 108(2):171-82. PubMed ID: 11832208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole‑exome sequencing insights into synchronous bilateral breast cancer with discordant molecular subtypes.
    Hu SH; Gao B; Li ZJ; Yuan YC
    Oncol Lett; 2024 Dec; 28(6):595. PubMed ID: 39430730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoubiquitinated H2B, a Main Chromatin Target of Formaldehyde, Is Important for S-Phase Checkpoint Signaling and Genome Stability.
    Mishra S; Krawic C; Luczak MW; Zhitkovich A
    Mol Carcinog; 2024 Dec; 63(12):2414-2424. PubMed ID: 39254477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.